Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuping Tan

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Plant Science|July 1, 2022
Functional Characterization of UDP-Glycosyltransferases Involved in Anti-viral Lignan Glycosides Biosynthesis in <i>Isatis indigotica</i>Yuping Tan, Jian Yang, Yinyin Jiang, et al.
HIV Clinical Trials|February 23, 2016
Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT StudyDanielle P Porter, Jonathan Toma, Yuping Tan, et al.
BMC Cancer|February 25, 2010
Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancerMasakazu Toi, Jeff Sperinde, Weidong Huang, et al.
American Journal of Clinical Pathology|July 28, 2010
Comparison of central HER2 testing with quantitative total HER2 expression and HER2 homodimer measurements using a novel proximity-based assayWeidong Huang, Monica Reinholz, Jodi Weidler, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 14, 2009
Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISHChristine Desmedt, Jeff Sperinde, Fanny Piette, et al.
Molecular Cancer Therapeutics|January 9, 2003
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cellsPaul H Johnson, Roger P Walker, Steven W Jones, et al.
Theranostics|January 18, 2021
Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradationChunqi Liu, Liang Wang, Xiaocong Liu, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 14, 2009
A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissueYining Shi, Weidong Huang, Yuping Tan, et al.
Pathology Research International|December 15, 2010
Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor SpecimensJeffrey S Larson, Laurie J Goodman, Yuping Tan, et al.
Breast Cancer Research and Treatment|August 21, 2013
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancerAllan Lipton, Laurie Goodman, Kim Leitzel, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Plant Science|July 1, 2022
Functional Characterization of UDP-Glycosyltransferases Involved in Anti-viral Lignan Glycosides Biosynthesis in <i>Isatis indigotica</i>Yuping Tan, Jian Yang, Yinyin Jiang, et al.
HIV Clinical Trials|February 23, 2016
Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT StudyDanielle P Porter, Jonathan Toma, Yuping Tan, et al.
BMC Cancer|February 25, 2010
Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancerMasakazu Toi, Jeff Sperinde, Weidong Huang, et al.
American Journal of Clinical Pathology|July 28, 2010
Comparison of central HER2 testing with quantitative total HER2 expression and HER2 homodimer measurements using a novel proximity-based assayWeidong Huang, Monica Reinholz, Jodi Weidler, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 14, 2009
Quantitation of HER2 expression or HER2:HER2 dimers and differential survival in a cohort of metastatic breast cancer patients carefully selected for trastuzumab treatment primarily by FISHChristine Desmedt, Jeff Sperinde, Fanny Piette, et al.
Molecular Cancer Therapeutics|January 9, 2003
Multiplex gene expression analysis for high-throughput drug discovery: screening and analysis of compounds affecting genes overexpressed in cancer cellsPaul H Johnson, Roger P Walker, Steven W Jones, et al.
Theranostics|January 18, 2021
Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradationChunqi Liu, Liang Wang, Xiaocong Liu, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 14, 2009
A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissueYining Shi, Weidong Huang, Yuping Tan, et al.
Pathology Research International|December 15, 2010
Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor SpecimensJeffrey S Larson, Laurie J Goodman, Yuping Tan, et al.
Breast Cancer Research and Treatment|August 21, 2013
HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancerAllan Lipton, Laurie Goodman, Kim Leitzel, et al.
Pageof 3